Elanco Animal Health Reports Third Quarter 2024 Results

Third Quarter 2024 Financial Results Revenue of $1,030 million, organic constant currency growth of 1% Reported Net Income of$ 364 million, Adjusted Net Income of $66 million Adjusted EBITDA of$ 163 million, or 15.8% of Revenue Reported EPS of $0.73, Adjusted EPS of$ 0.13 Net leverage ratio of 4.3x Adjusted EBITDA Pre-tax gain of $640 million from July 2024 divestiture of the aqua business Tightening full year 2024 financial guidance to reflect current assumptions: Revenue of$ 4,420 to $4,450 million, ...